SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-150198
Filing Date
2020-05-22
Accepted
2020-05-22 16:46:14
Documents
15
Period of Report
2020-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d935677d8k.htm   iXBRL 8-K 65624
2 EX-3.1 d935677dex31.htm EX-3.1 5345
3 EX-10.1 d935677dex101.htm EX-10.1 166572
7 GRAPHIC g935677ex31.jpg GRAPHIC 5283
  Complete submission text file 0001193125-20-150198.txt   417258

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sgmo-20200518.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmo-20200518_lab.xml EX-101.LAB 18125
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmo-20200518_pre.xml EX-101.PRE 11403
14 EXTRACTED XBRL INSTANCE DOCUMENT d935677d8k_htm.xml XML 3489
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 20906598
SIC: 2836 Biological Products, (No Diagnostic Substances)